Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Biliary Tract Diseases

  Free Subscription

Articles published in Eur J Gastroenterol Hepatol

Retrieve available abstracts of 36 articles:
HTML format

Single Articles

    June 2023
  1. TARAR ZI, Farooq U, Gandhi M, Ghous G, et al
    Effect of radiofrequency ablation in addition to biliary stent on overall survival and stent patency in malignant biliary obstruction: an updated systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2023;35:646-653.
    PubMed     Abstract available

    April 2023
  2. DIAS B, Aguiar A, Morais CI, Nery FG, et al
    Correlation between individual autoantibodies and clinical features in primary biliary cholangitis: results of a retrospective longitudinal study.
    Eur J Gastroenterol Hepatol. 2023 Apr 17. doi: 10.1097/MEG.0000000000002565.
    PubMed     Abstract available

  3. LI Z, Xu D, Yu H, Jiang H, et al
    Meta-analysis of the timing of laparoscopic cholecystectomy after endoscopic retrograde cholangiopancreatography in patients with cholecystolithiasis and choledocholithiasis.
    Eur J Gastroenterol Hepatol. 2023 Apr 11. doi: 10.1097/MEG.0000000000002553.
    PubMed     Abstract available

  4. SHEHTA A, Elshobari M, Salah T, Sultan AM, et al
    Predictive factors of postendoscopic retrograde cholangiopancreatography pancreatitis for biliary complications in living-donor liver transplantation recipients.
    Eur J Gastroenterol Hepatol. 2023;35:359-364.
    PubMed     Abstract available

    March 2023
  5. SU S, Trinh A, Metz AJ, Speer T, et al
    Targeted liver ultrasound performed by an expert is the pivotal imaging examination for low phospholipid-associated cholelithiasis.
    Eur J Gastroenterol Hepatol. 2023;35:327-332.
    PubMed     Abstract available

  6. SCHELLHAAS B, Jesper D, Strobel D
    Contrast-enhanced ultrasound pattern of hepatocellular carcinoma in noncirrhotic liver - results from the prospective multicentre DEGUM CEUS HCC study.
    Eur J Gastroenterol Hepatol. 2023;35:313-319.
    PubMed     Abstract available

  7. SAYED A, Assis DN, Silveira MG, Deng Y, et al
    Outcomes of immunomodulator and advanced therapies for primary sclerosing cholangitis-associated inflammatory bowel disease.
    Eur J Gastroenterol Hepatol. 2023;35:270-274.
    PubMed     Abstract available

  8. LAFFUSA A, Ciaccio A, Elvevi A, Gallo C, et al
    Impact of metformin on the incidence of human cholangiocarcinoma in diabetic patients: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2023;35:241-247.
    PubMed     Abstract available

    February 2023
  9. KARAAHMET F, Kekilli M
    Endoscopic retrograde cholangiopancreatography-oriented surgery for accomplished treatment of Mirizzi syndrome: a single-center experience.
    Eur J Gastroenterol Hepatol. 2023 Feb 27:e002534.
    PubMed     Abstract available

    January 2023
  10. YU PJ, Ho CM, Hsiao CY, Wu YM, et al
    Longitudinal analysis of transplant candidates with primary sclerosing cholangitis in an Asian liver transplant center.
    Eur J Gastroenterol Hepatol. 2023 Jan 31. doi: 10.1097/MEG.0000000000002516.
    PubMed     Abstract available

  11. MURILLO PEREZ CF, Gerussi A, Trivedi PJ, Corpechot C, et al
    Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western Europe.
    Eur J Gastroenterol Hepatol. 2023;35:112-119.
    PubMed     Abstract available

  12. CHEN LJ, Wang XY, Dai JH, Tang ZG, et al
    Role of endoscopic ultrasound in the evaluation of unexplained extrahepatic bile duct dilatation.
    Eur J Gastroenterol Hepatol. 2023;35:73-79.
    PubMed     Abstract available

    July 2022
  13. MACEDO SILVA V, Freitas M, Sousa Magalhaes R, Curdia Goncalves T, et al
    Prognostic scores in post-endoscopic retrograde cholangiopancreatography acute pancreatitis: should we use all, some, or none?
    Eur J Gastroenterol Hepatol. 2022 Jul 14. pii: 00042737-990000000-00032.
    PubMed     Abstract available

    April 2022
  14. BOAL CARVALHO P, Magalhaes J, Dias de Castro F, Curdia Goncalves T, et al
    NSAIDs are not enough - a double blinded randomized controlled trial on the impact of intensive hydration for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Eur J Gastroenterol Hepatol. 2022 Apr 8. pii: 00042737-990000000-00014.
    PubMed     Abstract available

    February 2022
  15. KAMAL F, Ali Khan M, Lee-Smith W, Sharma S, et al
    Metal versus plastic stents in the management of benign biliary strictures: systematic review and meta-analysis of randomized controlled trials.
    Eur J Gastroenterol Hepatol. 2022 Feb 14. pii: 00042737-900000000-97089.
    PubMed     Abstract available

    December 2021
  16. GARRIDO I, Santos AL, Lopes J, Lopes S, et al
    "Hepatotoxicity in inflammatory bowel disease: mesalazine, the forgotten drug".
    Eur J Gastroenterol Hepatol. 2021;33.
    PubMed     Abstract available

    November 2021
  17. BAIDOUN F, Sarmini MT, Merjaneh Z, Moustafa MA, et al
    Controversial risk factors for cholangiocarcinoma.
    Eur J Gastroenterol Hepatol. 2021 Nov 12. pii: 00042737-900000000-97122.
    PubMed     Abstract available

    October 2021
  18. PU W, Luo G, Chen T, Jing L, et al
    Comparative analysis of epidemiology, etiology, and outcomes between elderly and young and middle-aged acute pancreatitis patients: a retrospective, single-center study.
    Eur J Gastroenterol Hepatol. 2021;33:1254-1259.
    PubMed     Abstract available

    September 2021
  19. PI B, Wang J, Tong Y, Yang Q, et al
    Immune-related cholangitis induced by immune checkpoint inhibitors: a systematic review of clinical features and management.
    Eur J Gastroenterol Hepatol. 2021 Sep 1. pii: 00042737-900000000-97150.
    PubMed     Abstract available

    August 2021
  20. MENDEZ-SANCHEZ N, Valencia-Rodriguez A, Cerda-Reyes E, Montejo-Velazquez C, et al
    Long-standing effect of cholecystectomy in patients with metabolic-associated fatty liver disease.
    Eur J Gastroenterol Hepatol. 2021 Aug 16. pii: 00042737-900000000-97165.
    PubMed     Abstract available

  21. GARRIDO I, Liberal R, Cardoso MJ, Macedo G, et al
    The impact of undiagnosed primary biliary cholangitis.
    Eur J Gastroenterol Hepatol. 2021 Aug 16. pii: 00042737-900000000-97163.
    PubMed     Abstract available

    July 2021
  22. MUTNEJA HR, Bhurwal A, Attar BM, Vohra I, et al
    Efficacy and safety of primary needle-knife fistulotomy in biliary cannulation: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2021 Jul 19. pii: 00042737-900000000-97176.
    PubMed     Abstract available

    June 2021
  23. ELKERDAWY MA, Ahmed MH, Zaghloul MS, Haseeb MT, et al
    Does gallbladder wall thickness measurement predict esophageal varices in cirrhotic patients with portal hypertension?
    Eur J Gastroenterol Hepatol. 2021;33:917-925.
    PubMed     Abstract available

    May 2021
  24. PINYOPORNPANISH K, Chadalavada P, Talal Sarmini M, Khoudari G, et al
    Simplified 6-month prediction scores for primary biliary cholangitis patients treated with ursodeoxycholic acid.
    Eur J Gastroenterol Hepatol. 2021 May 31. pii: 00042737-900000000-97203.
    PubMed     Abstract available

    March 2021
  25. GAD MAM, Eraky TE, Omar HM, Abosheaishaa HM, et al
    Role of real-time shear-wave elastogarphy in differentiating hepatocellular carcinoma from other hepatic focal lesions.
    Eur J Gastroenterol Hepatol. 2021;33:407-414.
    PubMed     Abstract available

    February 2021
  26. EMARA MH, Ali RF, Mahmoud R, Mohamed SY, et al
    Postcholecystectomy biliary injuries: frequency, and role of early versus late endoscopic retrograde cholangiopancreatography.
    Eur J Gastroenterol Hepatol. 2021 Feb 5. pii: 00042737-900000000-97307.
    PubMed     Abstract available

  27. EMARA MH, Ahmed MH, Mohammed AS, Radwan MI, et al
    Biliary stent migration: why, how, and what?
    Eur J Gastroenterol Hepatol. 2021 Feb 5. pii: 00042737-900000000-97306.
    PubMed     Abstract available

  28. OH CH
    Direct visualization of anomalous pancreaticobiliary ductal union and pancreas divisum (with video).
    Eur J Gastroenterol Hepatol. 2021 Feb 5. pii: 00042737-900000000-97303.

    January 2021
  29. MAGRI S, Chessa L, Demurtas M, Cabras F, et al
    Review article: safety of new biologic agents for inflammatory bowel disease in the liver.
    Eur J Gastroenterol Hepatol. 2021 Jan 18. pii: 00042737-900000000-97310.
    PubMed     Abstract available

  30. SBEIT W, Greener T, Kadah A, Mari A, et al
    Pancreatic and hepatobiliary manifestations of nonalcoholic fatty pancreatic disease: a referral multi-center experience.
    Eur J Gastroenterol Hepatol. 2021 Jan 14. doi: 10.1097/MEG.0000000000002041.
    PubMed     Abstract available

  31. SELEEM WM, Hanafy AS, Abd-Elsalam S, Badawi R, et al
    Impact of laparoscopic cholecystectomy on the complexity of endoscopic retrograde cholangiopancreatography.
    Eur J Gastroenterol Hepatol. 2021;Publish Ahead of Print.
    PubMed     Abstract available

    December 2020
  32. WARNES TW, Roberts SA, Smith A, Cope VM, et al
    Portal hypertension in primary biliary cholangitis: prevalence, natural history and histological correlates.
    Eur J Gastroenterol Hepatol. 2020 Dec 14. doi: 10.1097/MEG.0000000000002033.
    PubMed     Abstract available

  33. MURILLO PEREZ CF, Gulamhusein A, Carbone M, Trivedi PJ, et al
    Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool.
    Eur J Gastroenterol Hepatol. 2020 Dec 14. doi: 10.1097/MEG.0000000000002029.
    PubMed     Abstract available

    November 2020
  34. PARIENTE A, Chazouilleres O, Causse X, Hanslik B, et al
    Management of primary biliary cholangitis: results from a large real-life observational study in France and Belgium.
    Eur J Gastroenterol Hepatol. 2020 Nov 30. doi: 10.1097/MEG.0000000000002011.
    PubMed     Abstract available

  35. LYUTAKOV I, Lozanov V, Sugareva P, Valkov H, et al
    Serum 7-alfa-hydroxy-4-cholesten-3-one and fibroblast growth factor-19 as biomarkers diagnosing bile acid malabsorption in microscopic colitis and inflammatory bowel disease.
    Eur J Gastroenterol Hepatol. 2020 Nov 10. doi: 10.1097/MEG.0000000000001925.
    PubMed     Abstract available

    October 2020
  36. ROY A, Premkumar M, Mishra S, Mehtani R, et al
    Role of ursodeoxycholic acid on maternal serum bile acids and perinatal outcomes in intrahepatic cholestasis of pregnancy.
    Eur J Gastroenterol Hepatol. 2020 Oct 29. doi: 10.1097/MEG.0000000000001954.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Biliary Tract Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.